23 results
8-K
EX-99.1
RLYB
Rallybio Corp
9 May 24
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
8:11am
delivery technology, and optimization work is ongoing.
First Quarter 2024 Financial Results
Research & Development (R&D) Expenses: R&D expenses were … $12.9 million for the first quarter of 2024, compared to $11.2 million for the same period in 2023. The increase in R&D expense was primarily due
8-K
EX-99.1
RLYB
Rallybio Corp
12 Mar 24
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
8:11am
and Full Year 2023 Financial Results
Research & Development (R&D) Expenses: R&D expenses were $15.9 million for the fourth quarter of 2023, compared … to $10.8 million for the same period in 2022. R&D expenses for the fourth quarter 2023 increased primarily due to an increase in costs to advance
8-K
EX-99.1
RLYB
Rallybio Corp
9 Nov 23
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
8:10am
Results:
Research & Development (R&D) Expenses: R&D expenses were $13.3 million for the third quarter of 2023, compared to $12.1 million for the same … period in 2022. The increase in R&D expenses was primarily due to an increase in costs to advance RLYB212 and RLYB331 and an increase in R&D related
8-K
EX-99.1
RLYB
Rallybio Corp
8 Aug 23
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
8:16am
& Development (R&D) Expenses: R&D expenses were $13.1 million for the second quarter of 2023, compared to $10.1 million for the same period in 2022. The increase … in R&D expenses was primarily due to an increase in costs to advance RLYB212 and RLYB116 and an increase in R&D related headcount costs, including
8-K
EX-99.1
yd2we
29 Jun 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
s2boy
9 May 23
Rallybio Reports First Quarter 2023 Financial Results
8:11am
8-K
EX-99.1
03buuhpec1c9sban91wz
7 Nov 22
Rallybio Reports Third Quarter 2022 Financial Results
8:03am
8-K
EX-99.1
e1y3vbqibe
8 Aug 22
Rallybio Reports Second Quarter 2022 Financial Results
8:30am
8-K
EX-99.2
w6ag6y
10 May 22
Rallybio Reports First Quarter 2022 Financial Results
4:01pm
8-K
EX-99.1
7ur9x5ha29o
10 May 22
Rallybio Reports First Quarter 2022 Financial Results
4:01pm
DEF 14A
uk0lqiod
25 Apr 22
Definitive proxy
5:03pm
8-K
EX-99.1
ze3 5hr3yz
15 Mar 22
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
8:30am
8-K
EX-99.1
aqlr 6dufjtdv
10 Nov 21
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
7:32am
8-K
EX-99.1
7o1kc16mcozyiaae1
9 Sep 21
Rallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business Highlights
4:11pm
424B4
rgutx
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
x30556f7y mug
22 Jul 21
IPO registration (amended)
4:04pm
S-1
l7lgluc4wp0xx62
2 Jul 21
IPO registration
4:28pm
S-1
EX-10.6
n7amnt0i2b
2 Jul 21
IPO registration
4:28pm